5'-Moemc-(Sp)-Moemc-(P)-Moea-(P)-Moemc-(P)-Moeg-(P)-Moea-(P)-Dmc-(Sp)-Da-(Sp)-Dt-(Sp)-Da-(Sp)-Dt-(Sp)-Dt-(Sp)-Dt-(Sp)-Dt-(Sp)-Dt-(Sp)-Dmc-(Sp)-Moet-(P)-Moea-(Sp)-Moemc-(Sp)-Moea 3'

1 trials Orphan designation

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

0 Completed trials

1 Sponsors

2 Countries

Phase III

Phase III: 1

Indications tested

Epileptic encephalopathy 1

Sponsors using this IMP

Praxis Precision Medicines Inc. 1

All trials

1 total

A Clinical Trial to Investigate the Efficacy, Safety and Pharmacokinetics of Elsunersen in Children Pending

2024-515598-82-00 Phase III 2 countries Praxis Precision Medicines Inc.

Showing 1–1 of 1 trials

← All drugs A–Z